HomeVIDHIING › Filing
🔔 Get instant alerts when VIDHIING files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 29 Jul 2026, 17:39 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Q1 FY27 revenue Rs 146.3 Cr, +66.4% y-y; EBITDA Rs 26.0 Cr, +26.7% y-y; PAT Rs 17.1 Cr, +34.7% y-y - EBITDA margin expanded by ~400 bps due to favorable product mix and higher cosmetic dye sales - Capacity expansions underway at Roha (200 MT/month) and Dahej (300 MT/month) with pilot plants ready - Strategic shift to specialty products and tablet coatings to drive new revenue streams - Exports to 80+ countries; strong regulatory compliance and diversified end-user sectors - Management emphasizes innovation-led growth and broadening product portfolio - Long customer approval cycles and high entry barriers sustain competitive advantage
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 VIDHIING — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add VIDHIING to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Vidhi Specialty Food Ingredients Limited

Important. The summary above is generated automatically from Vidhi Specialty Food Ingredients Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.